BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25821326)

  • 21. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.
    Gutiérrez-Macías A; Lizarralde-Palacios E; Martínez-Odriozola P; Miguel-De la Villa F
    BMJ; 2005 Sep; 331(7517):623-4. PubMed ID: 16166134
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute renal and hepatic failure associated with allopurinol treatment.
    Fagugli RM; Gentile G; Ferrara G; Brugnano R
    Clin Nephrol; 2008 Dec; 70(6):523-6. PubMed ID: 19049711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allopurinol induced generalized eosinophilic pustular folliculitis.
    Ooi CG; Walker P; Sidhu SK; Gordon LA; Marshman G
    Australas J Dermatol; 2006 Nov; 47(4):270-3. PubMed ID: 17034470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute generalized exanthematous pustulosis induced by iodixanol (Visipaque): a serious reaction to a commonly used drug.
    Ozturk U; Sungur MA; Karakas T; Mulayim K; Ozturk P
    Cutan Ocul Toxicol; 2015; 34(4):344-6. PubMed ID: 25363067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult with morbilliform rash and tattoo bullae.
    Borok J; Hau J; Worswick S
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute generalized exanthematous pustulosis as a manifestation of carbamazepine hypersensitivity syndrome.
    Son CH; Lee CU; Roh MS; Lee SK; Kim KH; Yang DK
    J Investig Allergol Clin Immunol; 2008; 18(6):461-4. PubMed ID: 19123438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing Life-Threatening Allopurinol Hypersensitivity.
    Stern RJ
    JAMA Intern Med; 2015 Sep; 175(9):1558. PubMed ID: 26192474
    [No Abstract]   [Full Text] [Related]  

  • 28. Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome with recurrence.
    Yang DC; Chang CM
    J Am Geriatr Soc; 2010 Oct; 58(10):2043-4. PubMed ID: 20929487
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hypersensitivity: Special care with allopurinol in certain risk groups].
    Middeke M
    Dtsch Med Wochenschr; 2015 Oct; 140(21):1577. PubMed ID: 26488092
    [No Abstract]   [Full Text] [Related]  

  • 30. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
    Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute generalized exanthematous pustulosis induced by celecoxib.
    Lee SK; Lee DY; Kim DJ; Kim MS; Lee UH; Hahm JH
    J Cutan Pathol; 2016 Jan; 43(1):80-1. PubMed ID: 26488335
    [No Abstract]   [Full Text] [Related]  

  • 32. The Janus faces of allopurinol-allopurinol hypersensitivity syndrome.
    Tausche AK; Aringer M; Schroeder HE; Bornstein SR; Wunderlich C; Wozel G
    Am J Med; 2008 Mar; 121(3):e3-4. PubMed ID: 18328291
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
    Matsuda-Hirose H; Sho Y; Yamate T; Nakamura Y; Saito K; Takeo N; Nishida H; Ishii K; Sugiura K; Hatano Y
    J Dermatol; 2020 Feb; 47(2):e53-e54. PubMed ID: 31840277
    [No Abstract]   [Full Text] [Related]  

  • 34. [Allopurinol-induced hypersensitivity syndrome].
    Kinyó A; Lakatos A; Varga A; Gyulai R; Varga E; Bata-Csörgő Z; Kemény L
    Orv Hetil; 2012 Apr; 153(15):586-91. PubMed ID: 22472359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The allopurinol hypersensitivity syndrome.
    Pluim HJ; van Deuren M; Wetzels JF
    Neth J Med; 1998 Mar; 52(3):107-10. PubMed ID: 9599967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to prevent allopurinol hypersensitivity reactions?
    Stamp LK; Barclay ML
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i35-i41. PubMed ID: 29272508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute generalized exanthematous pustulosis associated with 2 common medications: hydroxyzine and benzocaine.
    O'Toole A; Lacroix J; Pratt M; Beecker J
    J Am Acad Dermatol; 2014 Oct; 71(4):e147-9. PubMed ID: 25219740
    [No Abstract]   [Full Text] [Related]  

  • 39. Allopurinol hypersensitivity syndrome.
    Lee SS; Lin HY; Wang SR; Tsai YY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Aug; 27(3):140-7. PubMed ID: 9747344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approach to the treatment of hyperuricemia.
    Poon SH; Hall HA; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.